Spot on Saxman. The more the board tries to legitimise the trial result by pointing to differences between the original studies and the recent one, the more they taint their credibility.
In my opinion, not enough diligence was undertaken beforehand, for it it was, I doubt the prior results would have been spruiked the way they were.
Also to Supertramp, thanks for digging up that set of pre-readout quotes.
Ann: Shareholder Update, page-14
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
